BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31005214)

  • 1. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort.
    Nomden CN; Pötter R; de Leeuw AAC; Tanderup K; Lindegaard JC; Schmid MP; Fortin I; Haie-Meder C; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Huang F; Cooper R; Van Der Steen Banasik E; Van Limbergen E; Jürgenliemk-Schulz IM;
    Radiother Oncol; 2019 May; 134():185-190. PubMed ID: 31005214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis.
    Peters M; de Leeuw AAC; Nomden CN; Tanderup K; Kirchheiner K; Lindegaard JC; Kirisits C; Haie-Meder C; Sturdza A; Fokdal L; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Huang F; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Tan LT; van Rossum PSN; Nesvacil N; Nout R; Schmid MP; Pötter R; Jürgenliemk-Schulz IM;
    Radiother Oncol; 2021 Oct; 163():150-158. PubMed ID: 34480958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
    Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
    Bacorro W; Dumas I; Escande A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C
    Gynecol Oncol; 2018 Mar; 148(3):461-467. PubMed ID: 29325690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
    Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
    Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
    Najjari Jamal D; Pötter R; Haie-Meder C; Lindegaard JC; Juergenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Tanderup K; Kirchheiner K;
    Radiother Oncol; 2018 Jun; 127(3):449-455. PubMed ID: 29631933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer.
    Bacorro W; Dumas I; Levy A; Rivin Del Campo E; Canova CH; Felefly T; Huertas A; Marsolat F; Haie-Meder C; Chargari C; Mazeron R
    Brachytherapy; 2017; 16(2):366-372. PubMed ID: 28159552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
    BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
    Tiwari R; Narayanan GS; Reddy VP; Vishwanathan B; Narayanan S; Venugopal R
    Gynecol Oncol; 2021 Oct; 163(1):110-116. PubMed ID: 34304907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography.
    Rajasooriyar C; Van Dyk S; Lindawati M; Bernshaw D; Kondalsamy-Chennakesavan S; Narayan K
    Int J Gynecol Cancer; 2012 Nov; 22(9):1532-7. PubMed ID: 23027037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.
    Ariga T; Toita T; Kasuya G; Nagai Y; Inamine M; Kudaka W; Kakinohana Y; Aoki Y; Murayama S
    J Radiat Res; 2013 Jul; 54(4):690-6. PubMed ID: 23365264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who can benefit from a lymph node boost in definitive chemoradiotherapy for node-positive cervical cancer: an evaluation of nodal failure in patients without nodal boost.
    Kim H; Park W; Cho WK
    J Radiat Res; 2020 May; 61(3):479-486. PubMed ID: 32211854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
    Chung YL; Horng CF; Lee PI; Chen FL
    BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
    Lin AJ; Ma S; Markovina S; Schwarz J; Mutch DG; Powell MA; Grigsby PW
    Gynecol Oncol; 2019 Jun; 153(3):530-534. PubMed ID: 30905434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.
    Adam JA; Arkies H; Hinnen K; Stalpers LJ; van Waesberghe JH; Stoker J; van Os R; Laan JJ; Mom CH; van Eck-Smit BL
    Q J Nucl Med Mol Imaging; 2018 Dec; 62(4):420-428. PubMed ID: 29869485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
    Snyder JE; Willett AB; Sun W; Kim Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.